Home›Search›Cardiovascular and Hematological Disorders - Drug Targets

Cardiovascular and Hematological Disorders - Drug Targets

Bentham Science Publishers · United Arab Emirates · Est. 2006

ISSN2212-4063

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Norwegian Register Level 152

✓ Corroboration (1 more)+6

Total58

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.236

H-Indexi

SNIPi

0.278

Total Worksi

644

Total Citationsi

8,268

2yr Mean Citednessi

0.85

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Cardiovascular and Hematological Disorders - Drug Targets covers developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of molecular targets involved in cardiovascular and hematological disorders. It focuses on disease-specific proteins, receptors, enzymes, and genes.

AI-compiled from public web sources · verify on the publisher page

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published2006

Annual Volume~ 34 articles / year

StatusActive (last: 2026)

Total Publications644

Publisher OrgBentham Science Publishers

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2212-4063

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

230

2019

142

2020

211

2021

2022

102

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ4

HematologyQ4

Medicine (miscellaneous)Q4

Molecular MedicineQ4

PharmacologyQ4

Subject Classification

Scopus Categories

Molecular MedicinePharmacologyHematologyCardiology and Cardiovascular MedicineMedicine (miscellaneous)

Research Topics (OpenAlex)

Diverse Scientific and Economic StudiesAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesNatural Antidiabetic Agents StudiesLipoproteins and Cardiovascular HealthVenous Thromboembolism Diagnosis and ManagementDiabetes Treatment and ManagementAtherosclerosis and Cardiovascular DiseasesPlatelet Disorders and TreatmentsCardiovascular Function and Risk Factors

Frequently asked questions about Cardiovascular and Hematological Disorders - Drug Targets

Is Cardiovascular and Hematological Disorders - Drug Targets a predatory journal?

PubScope has no integrity flags on record for Cardiovascular and Hematological Disorders - Drug Targets: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 58/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cardiovascular and Hematological Disorders - Drug Targets?

Cardiovascular and Hematological Disorders - Drug Targets is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.236.

Is Cardiovascular and Hematological Disorders - Drug Targets indexed in Scopus and Web of Science?

Cardiovascular and Hematological Disorders - Drug Targets is indexed in Scopus.